Publisher
Springer Berlin Heidelberg
Reference29 articles.
1. Albers P, Ulbright TM, Albers J et al. (1996) Tumor proliferative activity is predictive of pathological stage in clinical stage A non-seminomatous testicular germ cell tumors. J Urol 155:579–586
2. Albers P, Bierhoff E, Neu D, Fimmers R, Wernert N, Müller SC (1997) MIB-1 immunohistochemistry predicts patients at low risk of metastasis in clinical stage I nonseminomatous testicular germ cell tumors. Cancer 79:1710–1716
3. Albers P, Siener R, Kliesch S et al. for the GTCSG and the German Association of Urologic Oncology (2003) Risk factors for relapse in clinical stage I non-seminomatous testicular germ cell tumors (NSGCT). Results of the German Testicular Cancer Study Group (GTCSG) trial. J Clin Oncol 21:1505–1512
4. Albers P, Albrecht W, Algaba F et al. (2005) European Association of Urology (EAU). Guidelines on testicular cancer. Eur Urol 48:885–894
5. Albers P, Bokemeyer C, Krege S, Souchon H (2006) Leitlinien zur Diagnostik und Therapie von Hodentumoren. Interdisziplinäre Leitlinien Onkologie der Deutschen Krebsgesellschaft. Zuckschwerdt, München